Z92.2 - Personal history of drug therapy
- Applicable to Personal history of drug therapy
- The 2025 edition of ICD10-CM Z92.2 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z92.2 - other international versions of ICD10 Z92.2 may differ.
- Z92.2 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Z92.2 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- Z92.2 - Personal history of drug therapy
- Z92.2 - Personal history of drug therapy
- Z92.21 - Personal history of antineoplastic chemotherapy
- Z92.22 - Personal history of monoclonal drug therapy
- Z92.23 - Personal history of estrogen therapy
- Z92.24 - Personal history of steroid therapy
- Z92.240 - Personal history of inhaled steroid therapy
- Z92.241 - Personal history of systemic steroid therapy
- Z92.25 - Personal history of immunosuppression therapy
- Z92.26 - Personal history of immune checkpoint inhibitor therapy
- Z92.29 - Personal history of other drug therapy
Type 2 Excludes
- long term (current) drug therapy (Z79.-)
The following codes above Z92.2 contain annotation back-references that may be applicable to Z92.2:
Chapter: Z00-Z99 Factors influencing health status and contact with health services
Category: Z92 Personal history of medical treatment
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com